| [1] |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic The-rapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2):315-352.
|
| [2] |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会与全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1087.
|
| [3] |
Villani M, Ageno W, Grandone E, et al. The prevention and treatment of venous thromboembolism in pregnancy[J]. Expert Rev Cardiovasc Ther, 2017, 15(5):397-402.
|
| [4] |
Di Minno MN, Ambrosino P, Ambrosini F, et al. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis[J]. J Thromb Haemost, 2016, 14(5):964-972.
|
| [5] |
Villani M, Dentali F, Colaizzo D, et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort[J]. BMJ Open, 2015, 5(10):e008213.
|
| [6] |
Hansen AT, Kesmodel US, Juul S, et al. Increased venous thrombosis incidence in pregnancies after in vitro fertilization[J]. Hum Reprod, 2014, 29(3):611-617.
|
| [7] |
Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles[J]. Fertil Steril, 2012, 97(1):95-100.
|
| [8] |
Creanga AA, Syverson C, Seed K, et al. Pregnancy-Related Mortality in the United States, 2011-2013[J]. Obstet Gynecol, 2017, 130(2):366-373.
|
| [9] |
ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy[J]. Obstet Gynecol. 2018, 132(1):e1-e17.
|
| [10] |
RCOG, Royal College of Obstetricians & Gynaecologists. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk (Green-top Guideline No. 37a). 2004. p.Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk(Green-top Guideline No.[EB/OL.(2004-12-01)[201902-01].https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/
|
| [11] |
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy[J]. Blood Adv, 2018, 2(22):3317-3359.
|
| [12] |
Leung AN, Bull TM, Jaeschke R, et al. American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy[J]. Radiology, 2012, 262(2):635-646.
|
| [13] |
Committee on Practice Bulletins—Obstetrics, American College of Obstetricians and Gynecologists. Practice Bulletin No. 132: Antiphospholipid syndrome[J]. Obstet Gynecol, 2012, 120(6):1514-1521.
|
| [14] |
Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group[J]. N Engl J Med, 2000, 343(20):1439-1444.
|
| [15] |
Radulescu VC, D′Orazio JA. Venous Thromboembolic Disease in Children and Adolescents[J]. Adv Exp Med Biol, 2017, 906:149-165.
|
| [16] |
Heit JA. Epidemiology of venous thromboembolism[J]. Nat Rev Cardiol, 2015, 12(8):464-474.
|
| [17] |
Young G. Diagnosis and treatment of thrombosis in children: general principles[J]. Pediatr Blood Cancer, 2006, 46(5):540-546.
|
| [18] |
Gokce M, Altan I, Unal S, et al. Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors[J]. Blood Coagul Fibrinolysis, 2012, 23(5):434-439.
|
| [19] |
Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study[J]. JAMA, 2014, 311(11):1117-1124.
|
| [20] |
Hakoum MB, Kahale LA, Tsolakian IG, et al. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer[J]. Cochrane Database Syst Rev, 2018, 1:CD006649.
|
| [21] |
Posch F, Königsbrügge O, Zielinski C, et al. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants[J]. Thromb Res, 2015, 136(3):582-589.
|
| [22] |
Turpie AGG, Purdham D, Ciaccia A. Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment[J]. Ther Adv Cardiovasc Dis, 2017, 11(9):243-256.
|
